<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To report an unusual case of clinical <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> seen with recurrent fetal loss, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, and recurrent <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo>, in which the only laboratory marker was M5-type antimitochondrial autoantibodies (AMA) </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Case report </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: University general hospital, tertiary level of clinical care </plain></SENT>
<SENT sid="3" pm="."><plain>Institutional practice </plain></SENT>
<SENT sid="4" pm="."><plain>PATIENT(S): A 65-year-old woman with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> associated with <z:e sem="disease" ids="C0085409" disease_type="Disease or Syndrome" abbrv="">autoimmune polyglandular syndrome</z:e> of IIIC type </plain></SENT>
<SENT sid="5" pm="."><plain>INTERVENTION(S): Clinical history and biochemical and immunologic markers </plain></SENT>
<SENT sid="6" pm="."><plain>MAIN OUTCOME MEASURE(S): The presence of M5-type AMA in clinical <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> isolated by indirect immunofluorescence </plain></SENT>
<SENT sid="7" pm="."><plain>RESULT(S): During the 10-year follow-up, immunologic studies detected a persistent positive M5-type AMA at high titer (1/640), antithyroid antibodies, anti-gastric parietal cells, and anti-intrinsic factor </plain></SENT>
<SENT sid="8" pm="."><plain>Antinuclear, anti-DNA, and antiphospholipid (anticardiolipin, anti-beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I) autoantibody tests were <z:hpo ids='HP_0000001'>all</z:hpo> repeatedly negative </plain></SENT>
<SENT sid="9" pm="."><plain>Results of coagulation studies and negative <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> were <z:mpath ids='MPATH_458'>normal</z:mpath> on several occasions </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION(S): Our findings suggest the necessity of determining M5-type AMA in the study panel of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> diagnosis, particularly in the absence of other typical autoantibodies </plain></SENT>
</text></document>